Torrent Pharmaceuticals Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|
| Revenue | 2,611 | 2,448 | 2,380 |
| Operating Expense | 1,637 | 1,589 | 1,490 |
| Net Profit | 551 | 474 | 485 |
| Net Profit Margin | 21.10 | 19.36 | 20.38 |
| Earning Per Share | 16.28 | 14 | 14.33 |
| EBIDTA | 981 | 871 | 849 |
| Effective Tax Rate | 20.33 | 18.63 | 14.04 |
| Particulars | Jun 2025 |
|---|---|
| Revenue | 2611.00 |
| Operating Expense | 1637.00 |
| Net Profit | 551.00 |
| Net Profit Margin | 21.10 |
| Earning Per Share | 16.28 |
| EBIDTA | 981.00 |
| Effective Tax Rate | 20.33 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 8,532.90 | 7,695.20 | 6,742.32 |
| Operating Expenses Annual | 5,643.60 | 5,230.04 | 4,641.56 |
| Operating Profit Annual | 2,980.66 | 2,547.04 | 2,304.93 |
| Interest Annual | 303.04 | 297.68 | 236.29 |
| Depreciation | 223.52 | 199.36 | 194.91 |
| Net Profit Annual | 1,357.08 | 1,051.39 | 991.45 |
| Tax Annual | 559.49 | 525.63 | 474.76 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 8,532.90 |
| Operating Expenses Annual | 5,643.60 |
| Operating Profit Annual | 2,980.66 |
| Interest Annual | 303.04 |
| Depreciation | 223.52 |
| Net Profit Annual | 1,357.08 |
| Tax Annual | 559.49 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 104.86 | 85.40 | 65 |
| Cash Flow from Operations | 2,574.50 | 2,893.10 | 2,265.41 |
| Cash Flow from Investing | -470.09 | -296.07 | -2,325.75 |
| Cash Flow from Financing | -2,104.46 | -2,577.57 | 80.74 |
| Cash Flow at the End | 104.81 | 104.86 | 85.40 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 104.86 |
| Cash Flow from Operations | 2,574.50 |
| Cash Flow from Investing | -470.09 |
| Cash Flow from Financing | -2,104.46 |
| Cash Flow at the End | 104.81 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 37.01 | 34.93 | 33.10 |
| PBIT Margin (%) | 29.16 | 26.01 | 24.36 |
| PBT Margin (%) | 29.02 | 25.92 | 24.28 |
| Net PROFIT Margin (%) | 19.50 | 15.90 | 13.66 |
| Return On Networth / Equity (%) | 26.18 | 20.43 | 16.43 |
| Return On Networth /Employed (%) | 26.84 | 20.40 | 17.68 |
| Return On Assets (%) | 17.94 | 12.41 | 9.97 |
| Total Debt / Equity (X) | 0.41 | 0.60 | 0.62 |
| Asset Turnover Ratio (%) | 0.92 | 0.78 | 0.73 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 37.01 |
| PBIT Margin (%) | 29.16 |
| PBT Margin (%) | 29.02 |
| Net PROFIT Margin (%) | 19.50 |
| Return On Networth / Equity (%) | 26.18 |
| Return On Networth /Employed (%) | 26.84 |
| Return On Assets (%) | 17.94 |
| Total Debt / Equity (X) | 0.41 |
| Asset Turnover Ratio (%) | 0.92 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 8,008.21 | 7,994.88 | 6,275.21 |
| Total Current Assets Annual | 3,741.06 | 3,927.08 | 4,060.05 |
| Non Current Assets Annual | 8,635.53 | 8,944.85 | 7,092.51 |
| Total Shareholders Funds Annual | 6,828.76 | 6,455.96 | 6,345.42 |
| Total Assets Annual | 12,376.59 | 12,871.93 | 11,152.56 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 8,008.21 |
| Total Current Assets Annual | 3,741.06 |
| Non Current Assets Annual | 8,635.53 |
| Total Shareholders Funds Annual | 6,828.76 |
| Total Assets Annual | 12,376.59 |
EPS (INR)
Expected
16.19
Reported
16.19
Surprise
0.00%
Mar 2025
EPS beaten by 0.00%
Dec 2024
EPS beaten by 0.00%
Sep 2024
EPS beaten by 0.13%
